Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis

Infection and Immunity

Volumn 64, Issue 7, 1996, Pages 2431-2439

  Cheville, Norman F ^a,b   Olsen, Steven C ^a   Jensen, Allen E ^a   Stevens, Mark G ^a   Florance, Allison M ^b   Houng, Huo Shu H ^c   Susan Drazek, E ^c,d   Warren, Richard L ^c   Hadfield, Ted L ^d   Hoover, David L ^c  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL VIRULENCE; BACTERIUM MUTANT; BRUCELLA MELITENSIS; BRUCELLOSIS; CONTROLLED STUDY; DELETION MUTANT; GERMINAL CENTER; GOAT; IMMUNITY; LYMPHADENITIS; NONHUMAN; PLASMACYTOSIS; PRIORITY JOURNAL; VACCINATION;

EID: 8944225020     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.7.2431-2439.1996     Document Type: Article

References (32)

1. Andersen, T., and N. F. Cheville. 1986. Ultrastructural and morphometric analysis of Brucella abortus-infected trophoblasts in experimental placentitis. Bacterial replication occurs in rough endoplasmic reticulum. Am. J. Pathol. 124:226-237.
2. Araya, L. N., P. H. Elzer, G. E. Rowe, F. M. Enright, and A. J. Winter. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J. Immunol. 143:3330-3337.
3. Cheers, C. 1983. Pathogenesis and cellular immunity in experimental murine brucellosis. Dev. Biol. Stand. 56:237-246.
4. Cheville, N. F., M. G. Stevens, A. E. Jensen, F. M. Tatum, and S. M. Halling. 1993. Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of Brucella abortus. Am. J. Vet. Res. 54:1591-1597.
5. Cloectaert, A., I. Jacques, N. Bosseray, J. N. Limet, R. Bowden, G. Dubray, and M. Plommet. 1991. Protection conferred on mice by monoclonal antibodies directed against outer-membrane-protein antigens of Brucella. J. Med. Microbiol. 34:175-180.
6. Collins, F. M., and S. G. Campbell. 1982. Immunity to intracellular bacteria. Vet. Immunol. Immunopathol. 3:5-66.
7. 6a.Crawford, R. M., et al. 1996. Deletion of purE attenuates Brucella melitensis infection in mice. Infect. Immun. 64:2188-2192.
8. 6b.Crawford, R. M., et al. Unpublished observations.
9. Curtiss, R., III, S. M. Kelly, and J. O. Hassan. 1993. Live oral avirulent Salmonella vaccines. Vet. Microbiol. 37:397-405.
10. Díaz-Aparicio, E., C. Marín, B. Alonso-Urmeneta, V. Aragòn, S. Pèrez-Ortiz, M. Pardo, J. M. Blasco, R. Díaz, and I. Moriyòn. 1994. Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J. Clin. Microbiol. 32:1159-1165.
11. Drazek, E. S., H. H. Houng, R. M. Crawford, T. L. Hadfield, D. L. Hoover, and R. L. Warren. 1995. Deletion of purE attenuates Brucella melitensis 16M for growth in human monocyte-derived macrophages. Infect. Immun. 63: 3297-3301.
12. Formal, S. B., J. Bohner, H. Schneider, and L. S. Baron. 1960. Virulence of a nutritional mutant of Vibrio comma. Proc. Soc. Exp. Biol. Med. 103:359-361.
13. Formal, S. B., P. Gemski, Jr., L. S. Baron, and E. H. LaBrec. 1971. A chromosomal locus which controls the ability of Shigella flexneri to evoke keratoconjunctivitis. Infect. Immun. 3:73-79.
14. Garber, E. D., A. J. Hackett, and R. Franklin. 1952. The virulence of biochemical mutants of Klebsiella pneumoniae. Proc. Natl. Acad. Sci. USA 38:693-697.
15. Halling, S. H., P. G. Detilleux, F. M. Tatum, B. A. Judge, and J. E. Mayfield. 1991. Deletion of the BCSP31 gene of Brucella abortus by replacement. Infect. Immun. 59:3863-3868.
16. Hjelm, L. N., A. A. Branstrom, and R. L. Warren. 1990. Detection of restriction fragment length polymorphisms in clinical isolates and serially passaged Pseudomonas aeruginosa strains. J. Clin. Microbiol. 28:2178-2182.
17. Houng, H.-S., H. E. Drazek, N. J. Clements, T. L. Hadfield, D. L. Hoover, and R. L. Warren. Unpublished data.
18. Linde, K., V. Dentchev, V. Bondarenko, S. Marinova, B. Randhagen, M. Bratoyeva, Y. Tsvetanov, and Y. Komanova. 1990. Live Shigella flexneri 2a and Shigella sonnei I vaccine candidate strains with two attenuating markers. I. Construction of vaccine candidate strains with retained invasiveness but reduced intracellular multiplication. Vaccine 8:25-29.
19. Jones, L. M., C. Garcia-Carrillo, and G. G. Alton. 1973. Brucella melitensis Rev. 1 and Brucella abortus 45/20 vaccines in goats: serologic tests. Am. J. Vet. Res. 34:199-202.
20. Levine, M. M., D. Herrington, J. R. Murphy, J. G. Morris, G. Losonsky, B. Tall, A. A. Lindberg, S. Svenson, S. Baqar, M. E. Edwards, and B. Stacker. 1987. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Invest. 79:888-902.
21. McFarland, W. C., and B. A. D. Stocker. 1987. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella dublin and two strains of Salmonella typhimurium. Microb. Pathog. 3:129-141.
22. Meador, V. P., B. L. Deyoe, and N. F. Cheville. 1989. Pathogenesis of Brucella abortus infection of the mammary gland and supramammary lymph node of the goat. Vet. Pathol. 26:357-368.
23. Meador, V. P., W. A. Hagemoser, and B. L. Deyoe. 1988. Histopathologic findings in Brucella abortus-infected, pregnant goats. Am. J. Vet. Res. 49: 274-280.
24. O'Callaghan, D., D. Maskell, J. Tite, and G. Gougan. 1990. Immune responses in BALB-c mice following immunization with aromatic compound or purine-dependent Salmonella typhimurium strains. Immunology 69:184-189.
25. Phillips, M., B. L. Deyoe, and P. C. Canning. 1989. Protection of mice against Brucella abortus infection by inoculation with monoclonal antibodies recognizing Brucella O-antigen. Am. J. Vet. Res. 50:2158-2161.
26. Schurig, G. G. 1982. The immune response of goats vaccinated with low and high doses of Brucella melitensis Rev 1. Vet. Immunol. Immunopathol. 3:311-324.
27. Sigwart, D. F., B. A. D. Stocker, and J. D. Clements. 1989. Effect of a purA mutation on efficacy of Salmonella live-vaccine vectors. Infect. Immun. 57: 1858-1861.
28. Smith, H., and R. B. Fitzgeorge. 1964. The effect of opsonization with antiserum on the survival of Brucella abortus within bovine phagocytes. Br. J. Exp. Pathol. 45:672-674.
29. Smith, L. D., and F. Heffron. 1987. Transposon Tn5 mutagenesis of Brucella abortus. Infect. Immun. 55:2774-2776.
30. Stevens, M. G., S. C. Olsen, and N. F. Cheville. 1995. Comparative analysis of immune responses in cattle vaccinated with Brucella abortus strain 19 or strain Rb51. Vet. Immunol. Immunopathol. 44:223-235.
31. Tatum, F. M., P. G. Detilleux, and S. M. Halling. 1992. Construction of a Cu-Zn superoxide dismutase deletion mutant of Brucella abortus: analysis of survival in vitro in epithelial and phagocytic cells and in vivo in mice. Infect. Immun. 60:876-884.
32. Verger, J.-M., M. Grayon, E. Zundel, P. Lechopier, and V. Olivier-Bernardin. 1995. Comparison of the efficacy of Brucella suis strain 2 and Brucella melitensis Rev. 1 live vaccines against a Brucella melitensis experimental infection in pregnant ewes. Vaccine 13:191-196.